|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.22 USD | +0.08% |
|
+0.03% | +4.27% |
| Jan. 14 | Orthofix Medical Insider Sold Shares Worth $327,376, According to a Recent SEC Filing | MT |
| Nov. 08 | Stifel Nicolaus Upgrades Orthofix Medical to Buy, $24 Price Target | MT |
| Capitalization | 695M 675M 633M 561M 996M 60.82B 1.11B 7.59B 2.82B 25.04B 2.61B 2.55B 105B | P/E ratio 2024 * |
-7.27x | P/E ratio 2025 * | -19.2x |
|---|---|---|---|---|---|
| Enterprise value | 695M 675M 633M 561M 996M 60.82B 1.11B 7.59B 2.82B 25.04B 2.61B 2.55B 105B | EV / Sales 2024 * |
0.87x | EV / Sales 2025 * | 0.82x |
| Free-Float |
95.01% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Orthofix Medical Inc.
More recommendations
More press releases
| 1 day | +0.08% | ||
| 1 week | +0.03% | ||
| Current month | -0.68% | ||
| 1 month | +7.09% | ||
| 3 months | -9.07% | ||
| 6 months | +13.50% | ||
| Current year | +4.27% |
1 week
17.86
19.20
1 month
16.7919.20
Current year
16.5319.20
1 year
12.0820.73
3 years
9.5836.13
5 years
9.5848.50
10 years
9.5874.44
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2024-01-07 | |
Julie Andrews
DFI | Director of Finance/CFO | 54 | 2024-01-14 |
| Chief Operating Officer | - | 2006-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Paolucci
BRD | Director/Board Member | 65 | 2016-03-15 |
Jason Hannon
BRD | Director/Board Member | 53 | 2020-06-07 |
John Henneman
BRD | Director/Board Member | 63 | 2023-01-04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.27% | 27 M€ | -0.21% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.08% | +0.03% | +26.42% | -41.10% | 695M | ||
| +1.27% | +1.90% | +16.32% | +2.45% | 224B | ||
| +0.67% | +0.15% | +6.58% | -13.55% | 115B | ||
| +0.38% | -6.59% | -4.96% | -14.94% | 66B | ||
| -0.36% | -2.83% | +7.50% | +74.67% | 48.07B | ||
| +0.90% | -9.37% | +6.02% | +18.96% | 43.05B | ||
| -0.78% | +0.29% | -26.28% | -21.04% | 34.4B | ||
| -1.29% | -4.86% | +2.52% | +33.02% | 27.55B | ||
| +0.15% | -4.47% | -20.82% | -19.42% | 23.29B | ||
| +0.08% | +2.54% | -0.47% | -4.00% | 21.93B | ||
| Average | +0.12% | -2.74% | +1.28% | +1.50% | 60.43B | |
| Weighted average by Cap. | +0.59% | -1.81% | +5.62% | +3.34% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 797M 773M 725M 643M 1.14B 69.66B 1.27B 8.69B 3.23B 28.67B 2.99B 2.93B 121B | 847M 822M 771M 684M 1.21B 74.07B 1.35B 9.24B 3.43B 30.49B 3.18B 3.11B 128B |
| Net income | -95.68M -92.8M -87.12M -77.24M -137M -8.37B -152M -1.04B -388M -3.44B -359M -351M -14.51B | -37.06M -35.94M -33.74M -29.91M -53.06M -3.24B -59.01M -404M -150M -1.33B -139M -136M -5.62B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,634
Calendar
2025-02-24
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-02-10 | 18.20 $ | +0.03% | 26,648 |
| 25-02-07 | 18.20 $ | -1.46% | 102,709 |
| 25-02-06 | 18.47 $ | -2.99% | 67,576 |
| 25-02-05 | 19.04 $ | +1.49% | 118,410 |
| 25-02-04 | 18.76 $ | +3.08% | 188,287 |
Delayed Quote Nasdaq, February 10, 2025 at 01:14 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.20USD
Average target price
24.30USD
Spread / Average Target
+33.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OFIX Stock